GlassScriptPhysician profile
Waqas Ali
NPI 1942861638
$11,595.71
in general payments reported to CMS, 2019-2025
13 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $10K · 2024: $1,102 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $1,583 · Travel and Lodging: $12.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $1,583.03 |
| Travel and Lodging | $12.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,094.11 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $456.18 | 2024 | Senza |
| Abbott Laboratories | $277.84 | 2023-2025 | Eterna, Proclaim |
| Inari Medical, INC. | $271.75 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $186.03 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Mml US, INC. | $132.30 | 2024 | Reactiv8 |
| Bioventus LLC | $46.87 | 2024-2025 | Xcell, Durolane |
| Painteq LLC | $38.76 | 2023 | Painteq |
| Averitas Pharma INC. | $26.67 | 2024 | Qutenza |
| Globus Medical, INC. | $18.20 | 2025 | Senza |
| Spinal Simplicity, LLC | $16.41 | 2025 | Ha Minuteman G3-R |
| Curonix LLC | $15.70 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $14.89 | 2024 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waqas Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.